Similar Items: Metalloproteinases and their inhibitors in the pathophysiology of heritable connective tissue disorders: current evidence
- Metalloproteinases and neurodegenerative diseases: pathophysiological and therapeutic perspectives
- Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives
- Matrix metalloproteinases in cystic fibrosis: pathophysiologic and therapeutic perspectives
- dCas9-mediated transcriptional activation of tissue inhibitor of metalloproteinases
- Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome
- Matrix metalloproteinases and their inhibitors in cardiovascular pathologies: current knowledge and clinical potential